CpGs associated with DNMT3A mutations, which tend to be hypomethylated, are more likely to reside in regions associated with gene expression (CGI shores), cancer (C-DMR), and cellular reprogramming (R-DMR). The gene discussed is DNMT3A; the disease is cancer.